iohexol has been researched along with Prostatic Neoplasms in 6 studies
Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.
Prostatic Neoplasms: Tumors or cancer of the PROSTATE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In sorafenib-treated tumors, significantly more apoptotic cells (TUNEL; 7132 ± 3141 vs." | 1.38 | Dynamic contrast-enhanced computed tomography imaging biomarkers correlated with immunohistochemistry for monitoring the effects of sorafenib on experimental prostate carcinomas. ( Bruns, CJ; Clevert, DA; Cyran, CC; Dietrich, O; Eschbach, R; Hinkel, R; Ingrisch, M; Nikolaou, K; Paprottka, PM; Reiser, MF; Schwarz, B; von Einem, JC; Wintersperger, BJ, 2012) |
| "Twenty-nine patients with biopsy-proven prostate cancer underwent a DCE-CT exam prior to radiotherapy." | 1.36 | The use of probability maps to deal with the uncertainties in prostate cancer delineation. ( Groenendaal, G; Korporaal, JG; Moman, MR; van den Berg, CA; van der Heide, UA; van Vulpen, M, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Korporaal, JG | 2 |
| van den Berg, CA | 2 |
| Groenendaal, G | 1 |
| Moman, MR | 1 |
| van Vulpen, M | 2 |
| van der Heide, UA | 2 |
| Messiou, C | 1 |
| Cook, G | 1 |
| Reid, AH | 1 |
| Attard, G | 1 |
| Dearnaley, D | 1 |
| de Bono, JS | 1 |
| de Souza, NM | 1 |
| Cyran, CC | 1 |
| von Einem, JC | 1 |
| Paprottka, PM | 1 |
| Schwarz, B | 1 |
| Ingrisch, M | 1 |
| Dietrich, O | 1 |
| Hinkel, R | 1 |
| Bruns, CJ | 1 |
| Clevert, DA | 1 |
| Eschbach, R | 1 |
| Reiser, MF | 1 |
| Wintersperger, BJ | 1 |
| Nikolaou, K | 1 |
| Osimani, M | 1 |
| Bellini, D | 1 |
| Di Cristofano, C | 1 |
| Palleschi, G | 1 |
| Petrozza, V | 1 |
| Carbone, A | 1 |
| Laghi, A | 1 |
| Beilicke, M | 1 |
| Klöppel, R | 1 |
| Schulze, M | 1 |
| Dorschner, W | 1 |
6 other studies available for iohexol and Prostatic Neoplasms
| Article | Year |
|---|---|
The use of probability maps to deal with the uncertainties in prostate cancer delineation.
Topics: Aged; Aged, 80 and over; Algorithms; Biopsy; Contrast Media; Humans; Imaging, Three-Dimensional; Ioh | 2010 |
The CT flare response of metastatic bone disease in prostate cancer.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Biomarkers, Tumor; Bone Neoplasms; Contrast Media; Di | 2011 |
Tracer kinetic model selection for dynamic contrast-enhanced computed tomography imaging of prostate cancer.
Topics: Aged; Aged, 80 and over; Computer Simulation; Contrast Media; Humans; Iohexol; Kinetics; Male; Metab | 2012 |
Dynamic contrast-enhanced computed tomography imaging biomarkers correlated with immunohistochemistry for monitoring the effects of sorafenib on experimental prostate carcinomas.
Topics: Animals; Antineoplastic Agents; Benzenesulfonates; Biomarkers; Cell Line, Tumor; Contrast Media; Ioh | 2012 |
Perfusion MDCT of prostate cancer: correlation of perfusion CT parameters and immunohistochemical markers of angiogenesis.
Topics: Aged; Biopsy; Contrast Media; Humans; Immunohistochemistry; Iohexol; Male; Middle Aged; Neovasculari | 2012 |
[Spiral CT vesiculography--a new examination technique in patients with histologically verified prostate carcinoma].
Topics: Aged; Contrast Media; Humans; Iohexol; Male; Middle Aged; Neoplasm Invasiveness; Prostate; Prostatic | 1998 |